B.Riley Downgrades Allena Pharmaceuticals (ALNA) to Neutral
Tweet
Share
E-mailGet Alerts ALNA Hot Sheet
Price: $0.08 --0%
Rating Summary:
5 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
5 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
B.Riley analyst Mayank Mamtani downgraded Allena Pharmaceuticals (NASDAQ: ALNA) from Buy to Neutral with a price target of $0.50 (from $3.00).
For an analyst ratings summary and ratings history on Allena Pharmaceuticals click here. For more ratings news on Allena Pharmaceuticals click here.
Shares of Allena Pharmaceuticals closed at $0.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
- AP Moller Maersk (MAERSKB:DC) (AMKBY) PT Raised to DKK20,864 at Citi
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
